FDA Warns Heart Patients About Antibiotic Clarithromycin

FRIDAY, Feb. 23, 2018 — The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.
As a result, the federal Food and Drug…
Source: Topamax